Standardized uptake value of 2-[18F] gluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy

Journal of Clinical Oncology

Volumn 20, Issue 5, 2002, Pages 1398-1404

  Allal, Abdelkarim S ^a   Dulguerov, Pavel ^a   Allaoua, Mohamed ^a   Haenggeli, Charles André ^a   El Ghazi, El Abbes ^a   Lehmann, Willy ^a   Slosman, Daniel O ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER SURVIVAL; DRUG UPTAKE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STANDARDIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0036498932     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.5.1398     Document Type: Article

References (24)

1. Impact of cervical disease and its definitive radiotherapeutic management on survival: Experience in 2013 patients with squamous cell carcinomas of the oropharynx and pharyngolarynx
2. Surfing prognostic factors in head and neck cancer at the millennium
3. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: An interim report
4. Tumor cell kinetics, local tumor control and accelerated radiotherapy: A preliminary report
5. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck
6. Fluorooxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo
7. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: Relation of positron emission tomography to flow cytometry
8. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxyglucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases - Leuven Lung Cancer Group
9. 18F]-D-glucose
10. 18FDG PET
11. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms
12. Value of positron emission tomography with 8-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma
13. Avoidance of treatment interruption: An unrecognized benefit of accelerated radiotherapy in oropharyngeal carcinomas?
14. Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: Evolution of a model beyond TNM staging
15. Predicting response to therapy of squamous cell carcinoma of the head and neck
16. Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck
17. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival
18. Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy
19. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer
20. Anatomy of SUV: Standardized uptake value
21. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia
22. Rapid rise in FDG uptake in an irradiated human tumour xenograft
23. Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: A preliminary observation